Ambea AB (FRA:6MA) Other Stockholders Equity: €-3 Mil (As of Mar. 2026)


FRA:6MA Ambea AB FRA:6MA
83 GF Score
Price €12.96
GF Value €10.83
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Ambea AB Other Stockholders Equity?

Ambea AB FRA:6MA -0.69% 83 Other Stockholders Equity is €-3 Mil as of Mar. 2026. GuruFocus rates FRA:6MA with a GF Score™ of 83/100 and a GF Value™ of €10.83 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Ambea AB's Other Stockholders Equity for the quarter that ended in Mar. 2026 was €-3 Mil.

Ambea AB's quarterly Other Stockholders Equity declined from Sep. 2025 (€-5 Mil) to Dec. 2025 (€-8 Mil) but then increased from Dec. 2025 (€-8 Mil) to Mar. 2026 (€-3 Mil).

Ambea AB's annual Other Stockholders Equity declined from Dec. 2023 (€-3 Mil) to Dec. 2024 (€-5 Mil) and declined from Dec. 2024 (€-5 Mil) to Dec. 2025 (€-8 Mil).

Ambea AB Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Ambea AB's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambea AB Other Stockholders Equity Chart

Ambea AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.31 3.46 -3.40 -4.61 -8.27

Ambea AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.57 -5.54 -5.27 -8.27 -2.51
FRA:6MA
83GF Score
Ambea AB FRA:6MA
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambea AB Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €-3 Mil mean?
Ambea AB (FRA:6MA) has a Other Stockholders Equity of €-3 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Ambea AB and its competitors.
Is Ambea AB's Other Stockholders Equity too high?
Ambea AB's current Other Stockholders Equity is €-3 Mil. Overall, Ambea AB has a GF Score™ of 83/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ambea AB's Other Stockholders Equity compare to HCA and THC?
Ambea AB's Other Stockholders Equity of €-3 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Healthcare Providers & Services company?
A good Other Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Ambea AB and its competitors. Ambea AB's current Other Stockholders Equity is €-3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambea AB stock overvalued right now?
Based on GuruFocus' analysis, Ambea AB (FRA:6MA) is currently considered Modestly Overvalued. The stock's GF Value™ is €10.83, compared to a current price of €12.96 — trading 19.7% above its estimated fair value. The current Other Stockholders Equity is €-3 Mil. Ambea AB's overall GF Score™ is 83/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Ambea AB (FRA:6MA), the current Other Stockholders Equity is €-3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ambea AB (FRA:6MA) Overvalued in 2026?

Based on GuruFocus' analysis, Ambea AB stock appears to be overvalued. The current stock price of €12.96 is trading 19.7% above its estimated GF Value™ of €10.83. GuruFocus considers Ambea AB to be Modestly Overvalued.

Key valuation signals for FRA:6MA:

  • Other Stockholders Equity: €-3 Mil
  • GF Value™: €10.83 vs. price of €12.96 (19.7% above fair value)
  • GF Score™: 83/100 with 8 warning signs

No single metric tells the full story. See the FRA:6MA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ambea AB Business Description

Address Rontgenvagen 3D, Box 1565, Solna, Stockholm, SWE, 171 29
Ambea AB is a Swedish care-provider group focused on elderly care, disability care, psychosocial support, housing, staffing, and training across the Nordic region. The company's segment includes: i) Nytida: Comprises social care services for children, youth and adults, in Sweden, ii) Vardaga: Comprises nursing homes and home care in Sweden, iii) Stendi: Comprises social care for children, youth and adult in Norway, iv) Validia: Comprises social care for children, v) Altiden: Comprises social care for children, youth and adults as well as elderly care in Denmark, and vi) Klara: Comprises competence and staffing solutions for elderly and social care, and student health services in Sweden. The majority of the company's revenue is derived from the Vardaga segment.
83GF Score

Get the complete analysis for FRA:6MA

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.96
Price
€10.83
GF Value